{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:24:18Z","timestamp":1790861058874,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.anl.2024.05.007","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T09:10:28Z","timestamp":1717837828000},"page":"755-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differential expression of epidermal growth factor receptor in various pathological types of salivary gland cancers"],"prefix":"10.1016","volume":"51","author":[{"given":"Hajime","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0274-2126","authenticated-orcid":false,"given":"Hikari","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-7545","authenticated-orcid":false,"given":"Hirotaka","family":"Shinomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-4871","authenticated-orcid":false,"given":"Ken-ichi","family":"Nibu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2024.05.007_bib0001","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1177\/014556131709600319","article-title":"The rising incidence of major salivary gland cancer in the United States","volume":"96","author":"Del Signore","year":"2017","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.anl.2024.05.007_bib0002","series-title":"WHO classification of tumors online","year":"2022"},{"key":"10.1016\/j.anl.2024.05.007_bib0003","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.otc.2015.11.001","article-title":"Diagnosis and management of malignant salivary gland tumors of the parotid gland","volume":"49","author":"Lewis","year":"2016","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.anl.2024.05.007_bib0004","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines): Head and Neck Cancers Version 2.2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf."},{"key":"10.1016\/j.anl.2024.05.007_bib0005","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1002\/hed.25857","article-title":"Prognostic markers in salivary gland cancer and their impact on survival","volume":"41","author":"Szewczyk","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2024.05.007_bib0006","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0714.2009.00770.x","article-title":"Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours","volume":"38","author":"Monteiro","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.anl.2024.05.007_bib0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2559.2008.03159.x","article-title":"Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas: EGFR and C-KIT in salivary gland cancer","volume":"53","author":"Ettl","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.anl.2024.05.007_bib0008","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1470-2045(11)70318-7","article-title":"EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study","volume":"13","author":"Pirker","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anl.2024.05.007_bib0009","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anl.2024.05.007_bib0010","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anl.2024.05.007_bib0011","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/hed.26529","article-title":"Therapeutic implications of immune-profiling and EGFR expression in salivary gland carcinoma","volume":"43","author":"Guazzo","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2024.05.007_bib0012","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.oraloncology.2012.05.005","article-title":"Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target","volume":"48","author":"Clauditz","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2024.05.007_bib0013","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.oraloncology.2008.07.010","article-title":"Cetuximab in recurrent and\/or metastatic salivary gland carcinomas: a phase II study","volume":"45","author":"Locati","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.anl.2024.05.007_bib0014","doi-asserted-by":"crossref","first-page":"979","DOI":"10.21873\/invivo.12790","article-title":"Retrospective study of Cisplatin\/Carboplatin, 5-Fluorouracil plus cetuximab (EXTREME) for advanced-stage salivary gland cancer","volume":"36","author":"Nakano","year":"2022","journal-title":"Vivo"},{"key":"10.1016\/j.anl.2024.05.007_bib0015","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.2007.11.8612","article-title":"Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands","volume":"25","author":"Agulnik","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anl.2024.05.007_bib0016","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hed.23647","article-title":"Phase II study of gefitinib in patients with advanced salivary gland cancers","volume":"37","author":"Jakob","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2024.05.007_bib0017","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-Infrared Photoimmunotherapy of Cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.anl.2024.05.007_bib0018","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.anl.2024.05.007_bib0019","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s10147-021-01960-6","article-title":"A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma","volume":"26","author":"Tahara","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.anl.2024.05.007_bib0020","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/hed.26885","article-title":"Phase 1\/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma","volume":"43","author":"Cognetti","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.anl.2024.05.007_bib0021","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/cas.14780","article-title":"Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes","volume":"112","author":"Hirata","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anl.2024.05.007_bib0022","doi-asserted-by":"crossref","first-page":"e10388","DOI":"10.1002\/btm2.10388","article-title":"Near-infrared-induced drug release from antibody-drug double conjugates exerts a cytotoxic photo-bystander effect","volume":"7","author":"Takahashi","year":"2022","journal-title":"Bioeng Transl Med"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814624000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814624000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T13:20:43Z","timestamp":1722172843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814624000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0385814624000671"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2024.05.007","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of epidermal growth factor receptor in various pathological types of salivary gland cancers","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2024.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}